Pro-Dex Net Common Equity Issued/Repurchased 2010-2024 | PDEX
Pro-Dex net common equity issued/repurchased from 2010 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
Pro-Dex Annual Net Common Equity Issued/Repurchased
(Millions of US $) |
| 2024 |
$-3 |
| 2023 |
$-1 |
| 2022 |
$-2 |
| 2021 |
$-5 |
| 2020 |
$-3 |
| 2019 |
$-4 |
| 2018 |
$2 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2015 |
$0 |
| 2014 |
$2 |
| 2013 |
$0 |
| 2012 |
$0 |
| 2011 |
$0 |
| 2010 |
$N/A |
| 2009 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.141B |
$0.054B |
|
Pro-Dex Inc., with operations in Santa Ana, California, Beaverton, Oregon and Carson City Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high tech manufacturing operations globally.
|
